Fig. 6
From: Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?
Changes in texture features of metastatic renal cancer following two cycles of a tyrosine kinase inhibitor: baseline (left) and following therapy (right). An increase in homogeneity is noted with treatment